OMOP Concept 2934877
magnesium aspartate 150 MG / magnesium oxide 70 MG / pyridoxine 4.06 MG / zinc, chelated 50 MG Oral Capsule
StandardDrugRxNorm ExtensionOMOP5151616Clinical Drug
Maps from
1
Descendants
3
Valid from
30 Jun 2021
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
1 source code normalizes to magnesium aspartate 150 MG / magnesium oxide 70 MG / pyridoxine 4.06 MG / zinc, chelated 50 MG Oral Capsule via the OMOP "Maps to" relationship.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(9)Roll up to these when you need a wider cohort.
Narrower concepts
(3)Included automatically when you query with descendants.
- 1magnesium aspartate 150 MG / magnesium oxide 70 MG / pyridoxine 4.06 MG / zinc, chelated 50 MG Oral Capsule Box of 90
- 1magnesium aspartate 150 MG / magnesium oxide 70 MG / pyridoxine 4.06 MG / zinc, chelated 50 MG Oral Capsule Box of 90 by Bioglan
- 1magnesium aspartate 150 MG / magnesium oxide 70 MG / pyridoxine 4.06 MG / zinc, chelated 50 MG Oral Capsule by Bioglan
Get this concept via the API
Resolve magnesium aspartate 150 MG / magnesium oxide 70 MG / pyridoxine 4.06 MG / zinc, chelated 50 MG Oral Capsule - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/2934877?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card